23andMe: See How This Company Is Making Millions Selling Customer DNA Information To Big Pharma
The leading privately-held personal genetics company, 23andMe, has found a new source of revenue after the Food and Drug Administration asked it to stop providing health-related information based on customer’s DNA. With services limited to ancestry data, the number of subscribers began to dwindle. However, the company has found a new way to survive. It […]
9y ago